James Cai
James Cai
Vice President; Head of Computational Innovation, Boehringer Ingelheim, USA
Elected to the Academy in 2026

Education

Sichuan University, BS, Biochemistry; University of Vermont, MS, Biochemistry; Cornell University – Weill Cornell Medicine, PhD, Molecular & Cell Biology; Columbia University, MA, Biomedical Informatics

Professional Areas

Dr. Cai is a world leader in data-driven computational drug discovery and development, where, through his various leadership roles, he develops innovative AI methods and tools to deepen understanding of human disease, discover novel drug targets and biomarkers, and accelerate drug discovery.

Citation

For exceptional contributions to the field of AI-driven drug discovery using large-scale integrative computational approaches, leveraging multidimensional and longitudinal human data, and the development of novel AI and other computational methods.